{"text": ["Lilly's", "Psoriasis", "Drug", "Found", "Superior", "To", "J&J's", "Tremfya", "In", "Phase", "4", "Study"], "created_at": "2019-08-13 15:40:14"}
{"text": ["Eli", "Lilly", "and", "Company", "(LLY)", "Ex-Dividend", "Date", "Scheduled", "for", "August", "14,", "2019"], "created_at": "2019-08-13 13:32:26"}
{"text": ["Eli", "Lilly", "and", "Company", "(LLY)", "Ex-Dividend", "Date", "Scheduled", "for", "August", "14,", "2019"], "created_at": "2019-08-13 13:32:26"}
{"text": ["8", "Stocks", "That", "Have", "Paid", "a", "Dividend", "for", "125", "(or", "More)", "Consecutive", "Years"], "created_at": "2019-08-13 11:07:26"}
{"text": ["8", "Stocks", "That", "Have", "Paid", "a", "Dividend", "for", "125", "(or", "More)", "Consecutive", "Years"], "created_at": "2019-08-13 11:07:26"}
{"text": ["Lilly", "Announces", "Superiority", "of", "Taltz\u00ae", "(ixekizumab)", "versus", "TREMFYA\u00ae", "(guselkumab)", "in", "Delivering", "Total", "Skin", "Clearance", "at", "Week", "12", "in", "Topline", "Results", "from", "Head-to-Head", "(IXORA-R)", "Trial", "in", "People", "Living", "with", "Moderate", "to", "Severe", "Plaque", "Psoriasis"], "created_at": "2019-08-13 10:45:00"}
{"text": ["8", "Stocks", "That", "Have", "Paid", "a", "Dividend", "for", "125", "(or", "More)", "Consecutive", "Years"], "created_at": "2019-08-13 10:06:00"}
{"text": ["How", "one", "Boston", "startup", "rode", "the", "diabetes", "investment", "wave", "to", "raise", "$126M"], "created_at": "2019-08-13 10:00:13"}
